Adia Med Inc. (OTCQB: ADIA) announced the completion of Phase 1 treatment for the first cohort of its Autism Spectrum ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE